Abilify | Indications/Uses

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage Patient Counseling Information MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Indications/Uses

ABILIFY Oral Tablets, Orally-Disintegrating Tablets, and Oral Solution are indicated for the treatment of: Schizophrenia [see Pharmacology: Pharmacodynamics: Clinical Studies: Schizophrenia under Actions]; Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder [see Pharmacology: Pharmacodynamics: Clinical Studies: Bipolar Disorder under Actions]; Adjunctive Treatment of Major Depressive Disorder [see Pharmacology: Pharmacodynamics: Clinical Studies: Adjunctive Treatment of Major Depressive Disorder under Actions]; Irritability Associated with Autistic Disorder [see Pharmacology: Pharmacodynamics: Clinical Studies: Irritability Associated with Autistic Disorder under Actions]; Treatment of Tourette's Disorder [see Pharmacology: Pharmacodynamics: Clinical Studies: Tourette's Disorder under Actions].

Abilify Indications/Uses

aripiprazole

Manufacturer:

Otsuka

Distributor:

Zuellig Pharma

Marketer:

Thai Otsuka